Post-Acute Sequelae After Severe Acute Respiratory Syndrome Coronavirus 2 Infection by Viral Variant and Vaccination Status: A Multicenter Cross-Sectional Study.

Publikation

Post-Acute Sequelae After Severe Acute Respiratory Syndrome Coronavirus 2 Infection by Viral Variant and Vaccination Status: A Multicenter Cross-Sectional Study.

Wissenschaftlicher Artikel/Review - 26.07.2023

Kahlert Christian, Strahm Carol, Güsewell Sabine, Cusini Alexia, Brucher Angela, Goppel Stephan, Möller Elisabeth, Möller J. Carsten, Ortner Manuela, Ruetti Markus, Stocker Reto, Vuichard-Gysin Danielle, Besold Ulrike, McGeer Allison J, Risch Lorenz, Friedl Andree, Schlegel Matthias, Vernazza Pietro L, Kuster Stefan, Kohler Philipp, SURPRISE (SURveillance of infectious diseases among health PRofessionals In SwitzErland) Study Group

Zitation

Kahlert C, Strahm C, Güsewell S, Cusini A, Brucher A, Goppel S, Möller E, Möller J, Ortner M, Ruetti M, Stocker R, Vuichard-Gysin D, Besold U, McGeer A, Risch L, Friedl A, Schlegel M, Vernazza P, Kuster S, Kohler P, SURPRISE (SURveillance of infectious diseases among health PRofessionals In SwitzErland) Study Group. Post-Acute Sequelae After Severe Acute Respiratory Syndrome Coronavirus 2 Infection by Viral Variant and Vaccination Status: A Multicenter Cross-Sectional Study. Clin Infect Dis 2023; 77:194-202.

Art

Wissenschaftlicher Artikel/Review (Englisch)

Zeitschrift

Clin Infect Dis 2023; 77

Veröffentlichungsdatum

26.07.2023

eISSN (Online)

1537-6591

Seiten

194-202

Kurzbeschreibung/Zielsetzung

Disentangling the effects of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants and vaccination on the occurrence of post-acute sequelae of SARS-CoV-2 (PASC) is crucial to estimate and reduce the burden of PASC.